Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Xiaoyang, Zhai"'
Autor:
Jinfa Ren, Xiaoyang Zhai, Huijia Yin, Fengmei Zhou, Ying Hu, Kaiyu Wang, Ruifang Yan, Dongming Han
Publikováno v:
Neurology and Therapy, Vol 12, Iss 5, Pp 1729-1743 (2023)
Abstract Introduction Conventional magnetic resonance imaging (MRI) features have difficulty distinguishing glioma true tumor recurrence (TuR) from treatment-related effects (TrE). We aimed to develop a machine-learning model based on multimodality M
Externí odkaz:
https://doaj.org/article/991ce177e77342c6846248cc0d63f1aa
Publikováno v:
Frontiers in Chemistry, Vol 11 (2023)
Existing elastic band materials for sports rehabilitation equipment have some deficiencies in strength, flexibility and durability, and need to be further improved. Therefore, the aim of this paper is to modify elastic bands using a conjugated materi
Externí odkaz:
https://doaj.org/article/a8c1de228c734659a5867503a847d0eb
Publikováno v:
Biochemistry and Biophysics Reports, Vol 34, Iss , Pp 101443- (2023)
Circulating tumor cells (CTCs) are a major cause of tumor metastasis and resistance to anticancer therapies. To date, no effective low-toxicity chemotherapeutic agents or antibodies have exhibited significant clinical activity against CTCs. Macrophag
Externí odkaz:
https://doaj.org/article/c89cbbcda57048e09e4cc673618c5ebf
Autor:
Xiaoyang Zhai, Wanhu Li, Ji Li, Wenxiao Jia, Wang Jing, Yaru Tian, Shuhui Xu, Yuying Li, Hui Zhu, Jinming Yu
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-12 (2021)
Abstract Background The study aimed to compare the efficacy of osimertinib plus cranial radiotherapy (RT) with osimertinib alone in advanced non-small-cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor (EGFR) mutations and b
Externí odkaz:
https://doaj.org/article/83f3d009099b488ba048e9be326475a0
Publikováno v:
Cancer Biology & Medicine, Vol 17, Iss 3, Pp 599-611 (2020)
Immune checkpoint inhibitors (ICIs) are new and promising therapeutic agents for non-small cell lung cancer (NSCLC). However, along with demonstrating remarkable efficacy, ICIs can also trigger immune-related adverse events. Checkpoint inhibitor pneu
Externí odkaz:
https://doaj.org/article/266daf61925447a7937b7fff36ac86ee
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Recently, the overall survival (OS) and progression-free survival (PFS) of patients with advanced cancer has been significantly improved due to the application of immune checkpoint inhibitors (ICIs). Low response rate and high occurrence of immune-re
Externí odkaz:
https://doaj.org/article/fbf7dbd12c784015a41efc0eac8a7f7c
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-12 (2019)
Abstract Small cell lung cancer (SCLC) is one of the deadliest cancer types in the world. Despite the high response rate to frontline platinum-containing doublets, relapse is inevitable for the majority of patients and the prognosis is poor. Topoteca
Externí odkaz:
https://doaj.org/article/5ca230a92cde4bd0a624d41855e573d0
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Purpose: The purpose of this study was to identify aberrant long non-coding RNAs (lncRNAs) and explore the predictive value of lncRNA expression patterns on the risk of brain metastases (BMs) in patients with limited-stage small-cell lung cancer (SCL
Externí odkaz:
https://doaj.org/article/544afccca1074d75a8bc66ec073cd69c
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundProgrammed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitor monotherapy has been approved as second-line or later therapy in advanced non-small-cell lung cancer (NSCLC). The study aimed to compare the clinical outcomes of PD-1 inh
Externí odkaz:
https://doaj.org/article/798f4d0c891b428fbc67e4e2764cfea4
Publikováno v:
Frontiers of Medicine. 16:610-617
Bevacizumab, an anti-VEGF monoclonal antibody, has significantly improved the clinical outcomes of patients with advanced non-squamous NSCLC (ns-NSCLC). However, the safety and efficacy of bevacizumab for elderly patients with advanced NSCLC require
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f49bb216959f514f219248bad0d3e1d8
https://doi.org/10.1007/s11684-021-0827-8
https://doi.org/10.1007/s11684-021-0827-8